Back to COLL

GOLDMAN SACHS GROUP INC → COLL

GOLDMAN SACHS GROUP INC COLL Position History

Collegium Pharmaceutical, Inc. • Healthcare

Quarters held
15
Latest value
$242K
Q3 2026
Peak value
$21M
First seen
Q2 2025

Dollar value over time

Show data table
PeriodPosition value
Q2 2025$2.4M
Q2 2025$4.6M
Q3 2025$20.1M
Q3 2025$8M
Q4 2025$9M
Q4 2025$21M
Q4 2025$21M
Q4 2025$9M
Q1 2026$15.3M
Q1 2026$3.7M
Q2 2026$15.6M
Q2 2026$4.5M
Q3 2026$5.1M
Q3 2026$10M
Q3 2026$242K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$242K11.1K——
Q3 2026$10M456.3K——
Q3 2026$5.1M234.1K——
Q2 2026$4.5M125.0K——
Q2 2026$15.6M431.9K——
Q1 2026$3.7M111.2K——
Q1 2026$15.3M463.9K——
Q4 2025$9M194.4K——
Q4 2025$21M453.1K——
Q4 2025$21M453.1K——
Q4 2025$9M194.4K——
Q3 2025$8M227.4K——
Q3 2025$20.1M574.8K——
Q2 2025$4.6M156.8K——
Q2 2025$2.4M80.0K——

Other funds holding COLL

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B